Skip to content

SCHEDULE 13G/AAccepted Feb 18, 1:46 PM ET

Quince Therapeutics, Inc. SCHEDULE 13G/A

Genextra S.p.A.

sec.gov(opens the filing on sec.gov)

Accepted (ET)

1:46 PM

Feb 18, 2025

Filed

Feb 18, 2025

Documents

1

Size

12.8 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.